New Chief Operating Officer
12.03.2013 - Zealand Pharma has appointed Agneta Svedberg as successor to Senior Vice President and Chief Operating Officer.
John Hyttel, who is retiring after 14 years with the company, The Master of Business Administration joins the Danish firm from Cantargia AB, a Swedish biotech company, where she has held a position as Chief Executive Officer. Agneta Svedberg brings in more than 20 years of experience in drug development from different leadership functions in both biotech and big pharma companies, including more than ten years with Genmab A/S in Copenhagen, where she was Global Head of Clinical Development and held various senior management positions. Prior to that, she was Head of Clinical Development (Europe) at Oxigene Europe AB and held managerial positions at Pharmacia & Upjohn AB in Sweden. Agneta Svedberg holds a M.Sc. in Radiation Physics from Lund University.http://www.european-biotechnology-news.com/people/bio-people/2013-01/agnata-svedberg.html